Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emiel F. M. Wouters has a total of 329 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lean Mass Index Adjustment of eGFR Strengthens Associations with Cardiometabolic Risk Factors

    by Oliver Helk, Charmaine J. M. Lim, Matthäus Metz, Emiel F. M. Wouters, Robab Breyer-Kohansal, Marie-Kathrin Breyer

    Background/Objectives: Serum creatinine (SCr)-based estimates of glomerular filtration rate (eGFRSCr) are influenced by muscle mass. This study investigated whether normalizing SCr to dual-energy X-ray absorptiometry (DEXA)-derived lean mass index (LMI) alters associations with cardiometabolic phenotypes. Methods: We analyzed 11,141 adults (mean age 46.0 ± 17.2 years) from the Austrian LEAD (Lung, hEart, sociAl, boDy) cohort. SCr was normalized to sex- and age-specific LMI reference values to calculate LMI-adjusted eGFR (eGFRLMISCr) within individuals. Associations with prevalent cardiometabolic conditions were compared using age- and sex-adjusted logistic regression with paired bootstrap resampling. Annualized eGFR change was compared in 7487 participants with complete follow-up measurements. Results: The estimates were closely correlated (R2 = 0.897), but LMI adjustment changed GFR-category assignment in both directions. Higher eGFRLMISCr was positively associated with prevalent dyslipidemia, hypertension, pre-diabetes, diabetes, metabolic syndrome and obesity. Differences in annualized change depended on age and sex, with lower LMI-adjusted slopes in women, particularly at younger ages, and higher slopes in men. Conclusion: LMI adjustment influences eGFR slopes in a sex- and age-specific manner and changes both filtration function category assignment and associations with cardiometabolic phenotypes. As these associations may partly reflect the direct incorporation of body composition into the estimate, our findings will require validation against measured GFR or an independent filtration marker.

  • Airway Resistance and conductance measured by body plethysmography over the adult age span

    by Emiel F. M. Wouters, Tobias Mraz, Charmaine Lim, Charles Irvin, David Kaminsky, Marie Breyer, Robab Breyer - Kohansal

    Specific airway resistance (sREFF) and conductance (sGaw) in adults are believed to be largely independent of age, height and sex. We aimed to investigate this hypothesis in a large healthy adult cohort. We investigated 3790 participants of the Austrian LEAD (Lung, hEart, sociAl, boDy) Study. Individuals who were ≥18years with no respiratory symptoms nor diagnosed disease and without use of inhalatives, never-smokers and normal post bronchodilator spirometry (FEV1, FVC and FEV1/FVC ≥-1.645 z-scores) were included. sREFF and sGaw were measured by body plethysmography. Neither parameter was normally distributed. Median values for sREFF and sGaw were 0.62 kPa.s and 1.61 1/(kPa.s), respectively. ULN defined by 97.5th percentile for sREFF is 1.14, the 2.5th percentile for sGaw is 0.88 kPa, corresponding to reported clinical cut offs. Although age appeared to influence both parameters, the effect was largely explained by height differences. Height was significantly associated with both measures, with taller height associated with higher sREFF and lower sGAW; however the absolute effect size was small, corresponding to an increase of 0.004 kPa.s-1 for sREFF and decrease of 0.01 kPa.s-1. L-1 in sGAW per 1 cm increase in height. Significant clinical impact of age or height is questionable as either have minimal effect. Therefore, we confirmed that sReff and sGaw were mainly independent of anthropometric factors in healthy adults, making these parameters a broadly useful measure of airway function and respiratory health. erj;68/suppl_70/PA3904/F1 F1 F1

  • Open Access

    Lean Mass Index Adjustment of eGFR Strengthens Associations with Cardiometabolic Risk Factors

    by Oliver Helk, Charmaine J.M. Lim, Matthäus Metz, Emiel F.M. Wouters, Robab Breyer-Kohansal, Marie-Kathrin Breyer

    Background/Objectives The accurate estimation of glomerular filtration rate (GFR) is essential for assessing trends in the prevalence (CKD), yet standard serum creatinine (SCr)-based estimates (eGFRSCr) are limited by individual variations in muscle mass. While demographic surrogates like age and sex are typically used to account for these variations, they often lead to eGFR misclassification in individuals. This study investi-gated whether normalizing SCr to Dual-energy X-ray absorptiometry (DEXA)-derived Lean Mass Index (LMI) improves the association with cardiometabolic risk. Methods We analyzed data from 11,143 adults (mean age 46.0 ± 17.2 years) in the Austrian LEAD (Lung, hEart, sociAl, boDy) cohort. Individual SCr concentrations were normalized to sex- and age-specific LMI reference values to calculate LMI-adjusted eGFR (eGFRLMISCr). The strength of associations between eGFRSCr and eGFRLMISCr with cardiometabolic risk factors (dyslipidemia, hypertension, pre-diabetes/diabetes, and metabolic syndrome) was compared using age- and sex-adjusted logistic regression with bootstrap resampling. Results While eGFRSCr and eGFRLMISCr were highly correlated (R2 = 0.897), LMI adjust-ment led to significant reclassification between CKD stages G1, G2, and G3a. eGFRLMISCr demonstrated significantly stronger associations with dyslipidemia, arterial hyperten-sion, pre-diabetes/diabetes, and metabolic syndrome compared to standard eGFRSCr. Longitudinal analysis showed that LMI adjustment stabilizes eGFR change estimates, particularly in younger men. Conclusion Adjusting serum creatinine for LMI signifi-cantly enhances the epidemiological utility of GFR estimation. GFRLMISCr improves car-diometabolic risk stratification, potentially offering a valuable method to "salvage" the utility and comparability of eGFRSCr in historic cohorts in early-stage filtration impair-ment in settings where DEXA but not Cystatin C is available.

  • Fatigue in COPD: a Longitudinal, Multidimensional Perspective

    by Zjala Ebadi, Yvonne M. J. Goërtz, Maarten Van Herck, Marc J. M. H. Delsing, Chris Burtin, Bram van Den Borst, Melissa S. Y. Thong, Erik W. M. A. Bischoff, Jean W. M. Muris, Judith Prins, et al.

    Background Fatigue is a pervasive, debilitating symptom of chronic obstructive pulmonary disease (COPD) that significantly impacts patients’ overall health and quality of life. However, its underlying mechanisms and associations with physical, psychological, behavioral, and other health factors remain unclear. This study investigated longitudinal associations between fatigue and these factors in COPD. Method A total of 247 COPD patients (mean age, 67.3 ± 8.1 years; 60% male; mean forced expiratory volume in 1 s (FEV1) 57 ± 21% predicted) from primary and secondary care were enrolled in a longitudinal observational study. Two-wave autoregressive cross-lagged panel models (ARCLM) examined relationships between fatigue and associated factors at baseline and 1 year later. Results Severe fatigue was prevalent in 53% of participants at baseline, with no significant change at follow-up. ARCLM findings indicated that baseline physical activity was the only predictor of reduced fatigue after 1 year. Moreover, higher baseline fatigue predicted poorer health-related quality of life, more severe dyspnea, and greater dyspnea-related emotional distress at follow-up. Although the initial focus was on fatigue, the analysis revealed a complex network of longitudinal relationships between multiple studied variables extending beyond fatigue. Conclusion Physical activity was the only direct predictor of fatigue, while fatigue directly influenced dyspnea, dyspnea-related emotions, and health-related quality of life. This study highlights the important role of fatigue within a complex network of physical, psychological, health status, and behavioral factors. The complexity of the interrelatedness of these factors suggests that single-target interventions are unlikely to be effective. Rather, integrated interventions, such as pulmonary rehabilitation, are needed.


  • Open Access

    Type-2 Inflammation in Health and Disease: Prevalence, Risk Factors and Multimorbidity

    by Charmaine J. M. Lim, Christoph Gross, Marie-Kathrin Breyer, Robab Breyer-Kohansal, Emiel F. M. Wouters, Sylvia Hartl

    Background: In patients with airflow obstruction, the levels of biomarkers of Type-2 (T2) inflammation serve to predict the effectiveness of inhaled corticosteroid and biological therapies. Elevated biomarkers of T2 inflammation, including fractional exhaled nitric oxide (FeNO, ≥20 ppb) and blood eosinophil counts (BEC, ≥300 cells/µL), were investigated in a population-based cohort of the Austrian LEAD study. Methods: A total of 4976 individuals (aged 18–82 years) were categorised into four groups based on their FeNO and BEC levels: normal with FeNO < 20 ppb and BEC < 300 cells/µL (n = 2634); FeNO ≥ 20 ppb only (n = 1623); BEC ≥ 300 cells/µL only (n = 340); and FeNO ≥ 20 ppb and BEC ≥ 300 cells/µL (n = 379). Results: In age- and sex-adjusted regression models, individuals with elevated BEC only were most associated with chronic cough and sputum production (odds ratios [95% CI]: 1.22 [0.78, 1.84] and 1.37 [1.13, 2.62], respectively), whilst individuals with both elevated T2 biomarkers were most associated with wheezing, dyspnoea and asthma (odds ratios [95% CI]: 2.27 [1.56, 3.26], 1.32 [0.64, 2.50] and 3.63 [2.69, 4.88] respectively). Elevated levels of both FeNO and BEC presented an additive effect in extrapulmonary conditions, particularly in allergy, eczema and rhino conjunctivitis (odds ratios [95% CI]: 2.30 [1.84, 2.88], 1.37 [1.03, 1.81] and 2.95 [2.34, 3.70], respectively). Conclusions: T2 inflammation marked by elevated levels of FeNO and/or BEC is not only associated with respiratory conditions but also extends to extrapulmonary characteristics, with an additive effect.


  • Association of inadequate social support and clinical outcomes in patients with chronic obstructive pulmonary disease – A cross-sectional study

    by Anna L. Stoustrup, Daisy J.A. Janssen, Nienke Nakken, Emiel F.M. Wouters, Alda Marques, Ulla Møller Weinreich, Martijn A. Spruit


  • Open Access

    The association of spirometric small airways obstruction with respiratory symptoms, cardiometabolic diseases, and quality of life: results from the Burden of Obstructive Lung Disease (BOLD) study

    by Ben Knox-Brown, Jaymini Patel, James Potts, Rana Ahmed, Althea Aquart-Stewart, Cristina Barbara, A. Sonia Buist, Hamid Hacene Cherkaski, Meriam Denguezli, Mohammed Elbiaze, et al.

    Background: Spirometric small airways obstruction (SAO) is common in the general population. Whether spirometric SAO is associated with respiratory symptoms, cardiometabolic diseases, and quality of life (QoL) is unknown. Methods: Using data from the Burden of Obstructive Lung Disease study (N = 21,594), we defined spirometric SAO as the mean forced expiratory flow rate between 25 and 75% of the FVC (FEF25-75) less than the lower limit of normal (LLN) or the forced expiratory volume in 3 s to FVC ratio (FEV3/FVC) less than the LLN. We analysed data on respiratory symptoms, cardiometabolic diseases, and QoL collected using standardised questionnaires. We assessed the associations with spirometric SAO using multivariable regression models, and pooled site estimates using random effects meta-analysis. We conducted identical analyses for isolated spirometric SAO (i.e. with FEV1/FVC ≥ LLN). Results: Almost a fifth of the participants had spirometric SAO (19% for FEF25-75; 17% for FEV3/FVC). Using FEF25-75, spirometric SAO was associated with dyspnoea (OR = 2.16, 95% CI 1.77–2.70), chronic cough (OR = 2.56, 95% CI 2.08–3.15), chronic phlegm (OR = 2.29, 95% CI 1.77–4.05), wheeze (OR = 2.87, 95% CI 2.50–3.40) and cardiovascular disease (OR = 1.30, 95% CI 1.11–1.52), but not hypertension or diabetes. Spirometric SAO was associated with worse physical and mental QoL. These associations were similar for FEV3/FVC. Isolated spirometric SAO (10% for FEF25-75; 6% for FEV3/FVC), was also associated with respiratory symptoms and cardiovascular disease. Conclusion: Spirometric SAO is associated with respiratory symptoms, cardiovascular disease, and QoL. Consideration should be given to the measurement of FEF25-75 and FEV3/FVC, in addition to traditional spirometry parameters.


  • Open Access

    The Pleiotropic Role of Vitamin K in Multimorbidity of Chronic Obstructive Pulmonary Disease

    by Ianthe Piscaer, Rob Janssen, Frits M. E. Franssen, Leon J. Schurgers, Emiel F. M. Wouters

    Although defined by the presence of airflow obstruction and respiratory symptoms, patients with chronic obstructive pulmonary disease (COPD) are characterized by multimorbidity. Numerous co-occurring conditions and systemic manifestations contribute to the clinical presentation and progression of COPD; however, underlying mechanisms for multimorbidity are currently not fully elucidated. Vitamin A and vitamin D have been related to COPD pathogenesis. Another fat-soluble vitamin, vitamin K, has been put forward to exert protective roles in COPD. Vitamin K is an unequivocal cofactor for the carboxylation of coagulation factors, but also for extra-hepatic proteins including the soft tissue calcification inhibitor matrix Gla-protein and the bone protein osteocalcin. Additionally, vitamin K has been shown to have anti-oxidant and anti-ferroptosis properties. In this review, we discuss the potential role of vitamin K in the systemic manifestations of COPD. We will elaborate on the effect of vitamin K on prevalent co-occurring chronic conditions in COPD including cardiovascular disorders, chronic kidney disease, osteoporosis, and sarcopenia. Finally, we link these conditions to COPD with vitamin K as a connecting factor and provide recommendations for future clinical studies.


  • Spirometry

    by E.F.M. Wouters, R. Breyer-Kohansal


  • Open Access

    Nutritional Status and Body Composition in Patients Suffering From Chronic Respiratory Diseases and Its Correlation With Pulmonary Rehabilitation

    by Emiel F. M. Wouters

    As part of an individualized intervention to improve the physical, emotional, and social functioning of patients with chronic respiratory diseases in general and chronic obstructive pulmonary disease in particular, awareness of the presence and consequences of changes in body composition increased enormously during the last decades, and nutritional intervention is considered as an essential component in the comprehensive approach of these patients. This review describes the prevalence and the clinical impact of body composition changes and also provides an update of current intervention strategies. It is argued that body composition, preferentially a three-component evaluation of fat, lean, and bone mass, must become part of a thorough assessment of every patient, admitted for pulmonary rehabilitation.